Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCQB - Delayed Quote USD

PreveCeutical Medical Inc. (PRVCF)

0.0180
0.0000
(0.00%)
At close: April 22 at 4:00:00 PM EDT

Key Executives

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Stephen Van Deventer Chairman, CEO & CFO 89.01k -- 1969
Dr. Makarand Jawadekar Ph.D. Chief Science Officer, President & Director 54.33k -- 1951

PreveCeutical Medical Inc.

5428 Marine Drive
Suite 2500
West Vancouver, BC V7W 2R2
Canada
https://www.preveceutical.com
Sector: 
Healthcare
Industry: 
Biotechnology

Description

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; BSV Peptide Program that targets cancer progression; and Dual Gene Therapy for type 2 diabetes and obesity. PreveCeutical Medical Inc. is headquartered in West Vancouver, Canada.

Corporate Governance

PreveCeutical Medical Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

July 14, 2017 at 12:00 AM UTC

Dividend Date

Related Tickers